Medications & Supplements/Prescription Drugs

Teva Pharmaceuticals USA: Acarbose (25 mg) Tablets Recalled for Incorrect Expiration Date

Agency Publication Date: September 28, 2017

Summary

Teva Pharmaceuticals has recalled 3,275 bottles of Acarbose Tablets (25 mg), a medication used to treat type 2 diabetes. The recall was issued because the bottles were printed with an incorrect expiration date of July 2018, when the correct expiration date is actually July 2017. Using medication past its intended shelf life may result in reduced effectiveness of the drug, which could affect blood sugar management.

Risk

The product labeling incorrectly extends the shelf life by one year, meaning patients may unknowingly consume the medication after it has expired. This poses a risk that the drug may have lost its potency, potentially leading to poorly controlled blood glucose levels.

What You Should Do

Check your medication bottle for Acarbose Tablets, 25 mg (100-count) with NDC 16252-523-01.
Verify the lot number and expiration date on the label; affected products are marked with Lot #: 1082710A and an expiration date of 07/18.
If you have this specific lot, contact your healthcare provider or pharmacist for guidance on obtaining a replacement and to ensure your treatment remains effective.
Return any unused product from this lot to your pharmacy for a refund.
Contact Teva Pharmaceuticals USA at their North Wales, PA location for further instructions regarding this recall.
For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

Full Refund

Pharmacy return and healthcare consultation

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Acarbose Tablets, 25 mg, 100-count bottle

Model:

NDC 16252-523-01

Recall #: D-1178-2017

Lot Numbers:

1082710A (Exp 07/18)

Date Ranges: July 2018 (Incorrect Date), July 2017 (Correct Date)

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 78060

Status: Resolved

Manufacturer: Teva Pharmaceuticals USA

Sold By: pharmacies

Manufactured In: Malta, United States

Units Affected: 3,275 bottles

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Check your medication bottle for Acarbose Tablets, 25 mg (100-count) with NDC 16252-523-01.

Verify the lot number and expiration date on the label; affected products are marked with Lot #: 1082710A and an expiration date of 07/18.

If you have this specific lot, contact your healthcare provider or pharmacist for guidance on obtaining a replacement and to ensure your treatment remains effective.

Return any unused product from this lot to your pharmacy for a refund.

Contact Teva Pharmaceuticals USA at their North Wales, PA location for further instructions regarding this recall.

For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.